Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 282, Issue 2 51-2, 2002, Pages

  Rodríguez Iturbe, Bernardo ^a,d   Quiroz, Yasmir ^a   Nava, Mayerly ^a   Bonet, Lizzette ^a   Chávez, Maribel ^a   Herrera Acosta, Jaime ^b   Johnson, Richard J ^c   Pons, Héctor A ^a  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b Department of Biochemistry   (Mexico)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NONE   (Venezuela)

Author keywords

Immune cells; Mycophenolate mofetil; Oxidative stress; Spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN; IMMUNOSUPPRESSIVE AGENT; MALONALDEHYDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HEREDITARY HYPERTENSION; IMMUNOCOMPETENT CELL; LYMPHOCYTE; MACROPHAGE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0036088786     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.0197.2001     Document Type: Article

References (69)

1. Heterogeneity in the appearance and distribution of macrophage subsets and their possible involvement in hypertensive vascular lesions in rats
2. Catalase
3. Mycophenolate mofetil and its mechanism of action
4. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts
5. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
6. Antihypertensive effect of an immunosuppressive agent, cyclophosphamide in genetically hypertensive rats of the Lyon strain
7. Immune system modulation and its effect on blood pressure of the spontaneously hypertensive male and female rat
8. Peridopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats
9. Improved method for the determination of blood glutathione
10. Superoxide production by polymorphonuclear leukocytes. A cytochemical approach
11. Elevation of plasma immunoglobulin A in the spontaneously hypertensive rat
12. Alterations of nitric oxide synthase expression with aging and hypertension in rats
13. The immune system and hypertension
14. Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: Inhibition of TNF-alpha and up regulation of IL-10 release
15. Alterations in lymphocyte populations during development in the spontaneously hypertensive rat
16. Prevention of the development of spontaneous hypertension in rats by captopril
17. Renal cortical vasoconstriction contributes to the development of salt-sensitive hypertension after angiotensin II exposure
18. Do immune system changes have a role in hypertension?
19. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney
20. Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR
21. Effect of mycophenolic acid on TNFα-induced expression of cell adhesion molecules in human venous endothelial cells in vitro
22. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
23. Pressure-induced constriction of the afferent arteriole of spontaneously hypertensive rats
24. Hypothesis: Is essential hypertension an acquired tubulointerstitial renal disease?
25. Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats
26. Associations between disturbances of the immune system and hypertension
27. Chronic immunosuppression attenuates hypertension in Okamoto spontaneously hypertensive rats
28. Thymectomy delays the development of hypertension in Okamoto spontaneously hypertensive rats
29. Variations in arterioles in spontaneously hypertensive rats. Morphometric analysis of afferent and efferent arterioles
30. Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Effects of ACE inhibition
31. Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecule-1 expression in vivo
32. Perindopril treatment prolonged the lifespan of spontaneously hypertensive rats
33. Immunopathogenic mechanisms in hypertension
34. Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats
35. Salt-sensitive hypertension develops after short-term exposure to angiotensin II
36. Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin
37. Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil
38. Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats
39. Immune system dysfunction contributes to the aetiology of spontaneous hypertension
40. Characterization of arterial antigens using arterial antigen-reactive T cell clones from spontaneously hypertensive rats
41. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
42. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
43. Spontaneously hypertensive rats: Lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation
44. Pharmacodynamic contribution to the vasodilator effect of chronic AT1 receptor blockade in SHR
45. Mycophenolate mofetil prevents the induction of active Heymann specific nephritis: Association with Th2 cytokine inhibition
46. Pathogenesis of cyclosporine nephropathy: Roles for angiotensin II and osteopontin
47. Immune system in the spontaneously hypertensive rat. II. Morphology and function
48. Mycophenolate mofetil (MMF) reduces renal lymphocyte infiltration and arterial pressure in spontaneously hypertensive rats (SHR)
49. Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition
50. Mesangial immune injury, hypertension and progressive damage in Dahl rats
51. Angiotensin II-mediated hypertension in the rat increase vascular superoxide production via membrane NADH-NADPH oxidase activation. Contribution to alterations of vasomotor tone
52. Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals
53. Partial transfer of genetic hypertension by lymphoid cells in the Lyon rat
54. The importance of the kidney in primary hypertension: Insights from cross-transplantation
55. Cyclosporine A reduces the expression of adhesion molecules in the kidney of rats with chronic serum sickness
56. The role of immunocompetent cells in non-immune renal diseases
57. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
58. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
59. Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit
60. 2α
61. Morphology of renal afferent arterioles in spontaneously hypertensive rats
62. Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension
63. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats
64. Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats
65. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: Hydroethydine microfluorography
66. Characterization of immunological depression in spontaneously hypertensive rats
67. Effect of antioxidant therapy in blood pressure and NO synthase expression in hypertensive rats
68. Angiotensin II type I receptor-mediated peroxide production in human macrophages
69. A new approach to the therapy of experimental mesangial proliferative glomerulonephritis